Changes in plasma thyroid hormone levels after a single dose of triiodothyronine in premature infants of less than 30 weeks gestational age

European Journal of Endocrinology

Volumn 143, Issue 6, 2000, Pages 733-740

  Cools, F ^a   Van Wassenaer, A G ^a   Kok, J H ^a   De Vijlder, J J M ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HORMONE INHIBITION; HORMONE RESPONSE; HUMAN; HYPOTHYROIDISM; INFANT; LIOTHYRONINE BLOOD LEVEL; MALE; PREMATURITY; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0034508377     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430733     Document Type: Article

References (31)

1. Reference ranges for newer thyroid function tests in premature infants
2. Thyroid function in very preterm infants: Influences of gestational age and disease
3. Thyroid function in the preterm infant: A longitudinal assessment
4. Editorial: The hypothyroxinemia of prematurity
5. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
6. Transient hypothyroxinemia associated with developmental delay in very preterm infants
7. The relation between neonatal thyroxine levels and the neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants
8. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants
9. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage
10. Low plasma triiodothyronine concentrations and outcome in preterm infants
11. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up
12. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation
13. 4 treatment of preterm newborns: Clinical and endocrine effects
14. Thyroxine administration to infants less than 30 weeks' gestational age does not increase plasma triiodothyronine concentrations
15. Thyroxine administration to infants less than 30 weeks gestational age decreases plasma tri-iodothyronine concentrations
16. Thyroid development and disorders of thyroid function in the newborn
17. Peripheral deiodination of thyroid hormones in placenta and fetal membranes
18. Thyroxine inner ring monodeiodinating activity in fetal tissues of the rat
19. The ontogeny of iodothyronine deiodinase systems in the liver and intestine of the rat
20. Serum iodothyronines in the human fetus and the newborn: Evidence for an important role of placenta in fetal thyroid hormone homeostasis
21. Role of sulfate in thyroid hormone sulfation
22. 3 metabolism in normal and type 1 deiodinase-deficient mice
23. Thyroid function in very preterm newborns: Possible implications
24. Quantitative aspects of hormone production, distribution, metabolism and activity
25. A novel X receptor-independent thyroid hormone response element is present in the human type I deiodinase gene
26. Thyrotropin and triiodothyronine regulate iodothyronine 5'-deiodinase messenger ribonucleic acid levels in FTRL-5 rat thyroid cells
27. Ontogeny of iodothyronine deiodinases in human liver
28. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: Evidence for a 'transient lazy thyroid system'
29. Reduction of mortality rate in premature infants by substitution of thyroid hormones
30. Molecular biological and biochemical characterisation of the human type 2 selenodeiodinase